Report error Found 35 Enz. Inhib. hit(s) with all data for entry = 50020501
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 930nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 370nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 790nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 890nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 123nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 1.30E+3nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 54nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 25nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 40nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 6nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 7nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 390nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 110nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 500nMAssay Description:Agonist activity at REV-ERBalpha LBD in HEK293 cells co-transfected with pG5-UAS pCMV-Gal4 incubated for 18 hrs by multimode plate reader analysisMore data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 120nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 10nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 20nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 160nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 1.00E+3nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 2.90E+3nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 70nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 990nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 20nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 80nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 330nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 50nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 580nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 70nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 610nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
TargetNuclear receptor subfamily 1 group D member 1(Human)
The Scripps Research Institute
Curated by ChEMBL
The Scripps Research Institute
Curated by ChEMBL
Affinity DataEC50: 950nMAssay Description:Agonist activity at his6-tagged human REV-ERBalpha LBD (281 to 614 residues) expressed in Escherichia coli assessed as increase in SMRT corepressor p...More data for this Ligand-Target Pair
